Menu
Search
|

Menu

Close
X

NeuroMetrix Inc NURO.OQ (NASDAQ Stock Exchange Capital Market)

1.24 USD
-0.03 (-2.36%)
As of Oct 19
chart
Previous Close 1.27
Open 1.27
Volume 16,969
3m Avg Volume 26,836
Today’s High 1.30
Today’s Low 1.24
52 Week High 2.96
52 Week Low 1.13
Shares Outstanding (mil) 2.13
Market Capitalization (mil) 4.00
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
3.00 Mean rating from 1 analysts

KEY STATS

Revenue (mm, USD)
FY18
12
FY17
17
FY16
12
FY15
7
EPS (USD)
FY18
0.204
FY17
-14.041
FY16
-61.237
FY15
-58.490
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
33.65
Price to Sales (TTM)
vs sector
0.25
5.82
Price to Book (MRQ)
vs sector
0.66
4.89
Price to Cash Flow (TTM)
vs sector
--
22.93
Total Debt to Equity (MRQ)
vs sector
0.00
17.17
LT Debt to Equity (MRQ)
vs sector
0.00
12.75
Return on Investment (TTM)
vs sector
-161.03
14.28
Return on Equity (TTM)
vs sector
-212.31
16.00

EXECUTIVE LEADERSHIP

Shai Gozani
Chairman of the Board, President, Chief Executive Officer, Secretary, Since 2008
Salary: $415,000.00
Bonus: $194,531.00
Thomas Higgins
Chief Financial Officer, Senior Vice President, Treasurer, Since 2009
Salary: $325,000.00
Bonus: $121,875.00
Francis McGillin
Senior Vice President, Chief Commercial Officer, Since 2016
Salary: $325,000.00
Bonus: $97,500.00
David Goodman
Independent Director, Since 2004
Salary: --
Bonus: --
Nancy Katz
Independent Director, Since 2010
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

1000 Winter St
WALTHAM   MA   02451-1436

Phone: +1781.8909989

NeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. The Company is engaged in the sale of medical equipment, and consumables and accessories. It has two principal product lines: Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. Its products include ADVANCE NCS/EMG System (the ADVANCE System), Quell, SENSUS and DPNCheck. Quell is a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems. The SENSUS pain therapy device, the technological predecessor to Quell, is a prescription neuro-stimulation device based on transcutaneous electrical nerve stimulation (TENS) for relief of chronic, intractable pain. DPNCheck is a quantitative nerve conduction test. ADVANCE System is a platform for the performance of traditional nerve conduction studies.

SPONSORED STORIES